Flatiron and NCCN continue partnership to improve cancer outcomes using real-world insights

The ongoing arrangement between Flatiron Health and the National Comprehensive Cancer Network (NCCN) highlights their joint commitment to using real-world data (RWD) to improve cancer care quality and patient outcomes.

Flatiron Health, affiliated with the Roche Group, and the National Comprehensive Cancer Network® (NCCN®), a nonprofit coalition of cancer centers, have announced the continuation of their collaboration to enhance cancer care quality through the utilization of RWD. Originating in 2014 with the establishment of the NCCN Quality & Outcomes Database, a cloud-based repository of data from NCCN Member Institutions, the renewed collaboration signifies an opportunity to further leverage RWD for research purposes, with a focus on enhancing the quality of care provided at cancer centers nationwide.

The renewed collaboration also marks an opportunity to further leverage RWD for research purposes, with a focus on enhancing the quality of care provided at cancer centers nationwide. By granting access to Flatiron’s curated oncology data sets, this initiative seeks to drive impactful research and inform decision-making processes in cancer care. Flatiron and NCCN will also continue to collaborate on quality improvement initiatives at participating NCCN Member Institutions. This involves the development of metrics and benchmarks to evaluate and enhance the quality of care delivered at these institutions, thereby fostering a culture of continuous improvement.

Crystal S Denlinger, CEO of NCCN, explained the shared goal of ensuring widespread access to evidence-based, high-quality cancer care,

“We strive to ensure that everyone, everywhere, is able to access high-quality cancer care based on the latest evidence and expert consensus. This ongoing collaboration with Flatiron will help us leverage data in pursuit of that goal. We are happy to renew our commitment to work together to help people with cancer live better lives.”

Neal Meropol, Vice President of Research Oncology at Flatiron Health, highlighted the importance of this collaboration in advancing their mission to improve and extend lives through real-world insights,

“The continuation of Flatiron’s long-standing relationship with NCCN is an exciting opportunity and step forward in executing our mission to improve and extend lives by learning from the experience of every person with cancer. This collaboration will expand the impact of real-world data in addressing evidence gaps and improving care standards along with leading cancer centers in the NCCN alliance.”